Selected research
Industry Research
Gadolinium-containing Contrast Agent Industry Research Report 2026
Market perspective
The global Gadolinium-containing Contrast Agent market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Gadolinium-containing Contrast Agent is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Gadolinium-containing Contrast Agent is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Gadolinium-containing Contrast Agent is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Gadolinium-containing Contrast Agent include among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Gadolinium-containing Contrast Agent market in revenue (US$ million) and, where applicable, sales volume (kt), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/kt) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Gadolinium-containing Contrast Agent.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Gadolinium-containing Contrast Agent Market by Company
GE
Daiichi Sankyo
BeiLu Pharma
Bayer
YRPG
Liebel-Flarsheim
Lantheus
Guerbet Group
Bracco Imaging
Gadolinium-containing Contrast Agent Segment by Type
Injection Type
Oral Type
Gadolinium-containing Contrast Agent Segment by Application
Research Medical Center
Hospitals
Clinics
Others
Gadolinium-containing Contrast Agent Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gadolinium-containing Contrast Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gadolinium-containing Contrast Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gadolinium-containing Contrast Agent.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Gadolinium-containing Contrast Agent manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Gadolinium-containing Contrast Agent by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Gadolinium-containing Contrast Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injection Type
- Oral Type
Applications
- Research Medical Center
- Hospitals
- Clinics
- Others
Companies covered
- GE
- Daiichi Sankyo
- BeiLu Pharma
- Bayer
- YRPG
- Liebel-Flarsheim
- Lantheus
- Guerbet Group
- Bracco Imaging
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Gadolinium-containing Contrast Agent by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Injection Type
- 2.2.3 Oral Type
- 2.3 Gadolinium-containing Contrast Agent by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Research Medical Center
- 2.3.3 Hospitals
- 2.3.4 Clinics
- 2.3.5 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Gadolinium-containing Contrast Agent Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Gadolinium-containing Contrast Agent Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Gadolinium-containing Contrast Agent Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Gadolinium-containing Contrast Agent Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Gadolinium-containing Contrast Agent Production by Manufacturers (2021-2026)
- 3.2 Global Gadolinium-containing Contrast Agent Production Value by Manufacturers (2021-2026)
- 3.3 Global Gadolinium-containing Contrast Agent Average Price by Manufacturers (2021-2026)
- 3.4 Global Gadolinium-containing Contrast Agent Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Gadolinium-containing Contrast Agent Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Gadolinium-containing Contrast Agent Manufacturers, Product Type & Application
- 3.7 Global Gadolinium-containing Contrast Agent Manufacturers Established Date
- 3.8 Global Gadolinium-containing Contrast Agent Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 GE
- 4.1.1 GE Gadolinium-containing Contrast Agent Company Information
- 4.1.2 GE Gadolinium-containing Contrast Agent Business Overview
- 4.1.3 GE Gadolinium-containing Contrast Agent Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 GE Product Portfolio
- 4.1.5 GE Recent Developments
- 4.2 Daiichi Sankyo
- 4.2.1 Daiichi Sankyo Gadolinium-containing Contrast Agent Company Information
- 4.2.2 Daiichi Sankyo Gadolinium-containing Contrast Agent Business Overview
- 4.2.3 Daiichi Sankyo Gadolinium-containing Contrast Agent Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Daiichi Sankyo Product Portfolio
- 4.2.5 Daiichi Sankyo Recent Developments
- 4.3 BeiLu Pharma
- 4.3.1 BeiLu Pharma Gadolinium-containing Contrast Agent Company Information
- 4.3.2 BeiLu Pharma Gadolinium-containing Contrast Agent Business Overview
- 4.3.3 BeiLu Pharma Gadolinium-containing Contrast Agent Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 BeiLu Pharma Product Portfolio
- 4.3.5 BeiLu Pharma Recent Developments
- 4.4 Bayer
- 4.4.1 Bayer Gadolinium-containing Contrast Agent Company Information
- 4.4.2 Bayer Gadolinium-containing Contrast Agent Business Overview
- 4.4.3 Bayer Gadolinium-containing Contrast Agent Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Bayer Product Portfolio
- 4.4.5 Bayer Recent Developments
- 4.5 YRPG
- 4.5.1 YRPG Gadolinium-containing Contrast Agent Company Information
- 4.5.2 YRPG Gadolinium-containing Contrast Agent Business Overview
- 4.5.3 YRPG Gadolinium-containing Contrast Agent Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 YRPG Product Portfolio
- 4.5.5 YRPG Recent Developments
- 4.6 Liebel-Flarsheim
- 4.6.1 Liebel-Flarsheim Gadolinium-containing Contrast Agent Company Information
- 4.6.2 Liebel-Flarsheim Gadolinium-containing Contrast Agent Business Overview
- 4.6.3 Liebel-Flarsheim Gadolinium-containing Contrast Agent Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Liebel-Flarsheim Product Portfolio
- 4.6.5 Liebel-Flarsheim Recent Developments
- 4.7 Lantheus
- 4.7.1 Lantheus Gadolinium-containing Contrast Agent Company Information
- 4.7.2 Lantheus Gadolinium-containing Contrast Agent Business Overview
- 4.7.3 Lantheus Gadolinium-containing Contrast Agent Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Lantheus Product Portfolio
- 4.7.5 Lantheus Recent Developments
- 4.8 Guerbet Group
- 4.8.1 Guerbet Group Gadolinium-containing Contrast Agent Company Information
- 4.8.2 Guerbet Group Gadolinium-containing Contrast Agent Business Overview
- 4.8.3 Guerbet Group Gadolinium-containing Contrast Agent Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Guerbet Group Product Portfolio
- 4.8.5 Guerbet Group Recent Developments
- 4.9 Bracco Imaging
- 4.9.1 Bracco Imaging Gadolinium-containing Contrast Agent Company Information
- 4.9.2 Bracco Imaging Gadolinium-containing Contrast Agent Business Overview
- 4.9.3 Bracco Imaging Gadolinium-containing Contrast Agent Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Bracco Imaging Product Portfolio
- 4.9.5 Bracco Imaging Recent Developments
5 Global Gadolinium-containing Contrast Agent Production by Region
- 5.1 Global Gadolinium-containing Contrast Agent Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Gadolinium-containing Contrast Agent Production by Region: 2021-2032
- 5.2.1 Global Gadolinium-containing Contrast Agent Production by Region: 2021-2026
- 5.2.2 Global Gadolinium-containing Contrast Agent Production Forecast by Region (2027-2032)
- 5.3 Global Gadolinium-containing Contrast Agent Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Gadolinium-containing Contrast Agent Production Value by Region: 2021-2032
- 5.4.1 Global Gadolinium-containing Contrast Agent Production Value by Region: 2021-2026
- 5.4.2 Global Gadolinium-containing Contrast Agent Production Value Forecast by Region (2027-2032)
- 5.5 Global Gadolinium-containing Contrast Agent Market Price Analysis by Region (2021-2026)
- 5.6 Global Gadolinium-containing Contrast Agent Production and Value, YOY Growth
- 5.6.1 North America Gadolinium-containing Contrast Agent Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Gadolinium-containing Contrast Agent Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Gadolinium-containing Contrast Agent Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Gadolinium-containing Contrast Agent Production Value Estimates and Forecasts (2021-2032)
6 Global Gadolinium-containing Contrast Agent Consumption by Region
- 6.1 Global Gadolinium-containing Contrast Agent Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Gadolinium-containing Contrast Agent Consumption by Region (2021-2032)
- 6.2.1 Global Gadolinium-containing Contrast Agent Consumption by Region: 2021-2026
- 6.2.2 Global Gadolinium-containing Contrast Agent Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Gadolinium-containing Contrast Agent Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Gadolinium-containing Contrast Agent Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Gadolinium-containing Contrast Agent Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Gadolinium-containing Contrast Agent Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Gadolinium-containing Contrast Agent Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Gadolinium-containing Contrast Agent Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Gadolinium-containing Contrast Agent Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Gadolinium-containing Contrast Agent Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Gadolinium-containing Contrast Agent Production by Type (2021-2032)
- 7.1.1 Global Gadolinium-containing Contrast Agent Production by Type (2021-2032) & (kt)
- 7.1.2 Global Gadolinium-containing Contrast Agent Production Market Share by Type (2021-2032)
- 7.2 Global Gadolinium-containing Contrast Agent Production Value by Type (2021-2032)
- 7.2.1 Global Gadolinium-containing Contrast Agent Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Gadolinium-containing Contrast Agent Production Value Market Share by Type (2021-2032)
- 7.3 Global Gadolinium-containing Contrast Agent Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Gadolinium-containing Contrast Agent Production by Application (2021-2032)
- 8.1.1 Global Gadolinium-containing Contrast Agent Production by Application (2021-2032) & (kt)
- 8.1.2 Global Gadolinium-containing Contrast Agent Production Market Share by Application (2021-2032)
- 8.2 Global Gadolinium-containing Contrast Agent Production Value by Application (2021-2032)
- 8.2.1 Global Gadolinium-containing Contrast Agent Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Gadolinium-containing Contrast Agent Production Value Market Share by Application (2021-2032)
- 8.3 Global Gadolinium-containing Contrast Agent Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Gadolinium-containing Contrast Agent Value Chain Analysis
- 9.1.1 Gadolinium-containing Contrast Agent Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Gadolinium-containing Contrast Agent Production Mode & Process
- 9.2 Gadolinium-containing Contrast Agent Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Gadolinium-containing Contrast Agent Distributors
- 9.2.3 Gadolinium-containing Contrast Agent Customers
10 Global Gadolinium-containing Contrast Agent Analyzing Market Dynamics
- 10.1 Gadolinium-containing Contrast Agent Industry Trends
- 10.2 Gadolinium-containing Contrast Agent Industry Drivers
- 10.3 Gadolinium-containing Contrast Agent Industry Opportunities and Challenges
- 10.4 Gadolinium-containing Contrast Agent Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst